Knowledge, attitude and practices of Swiss dairy farmers towards intramammary antimicrobial use and antimicrobial resistance : A latent class analysis

Understanding farmers’ mindsets is important to improve antimicrobial stewardship in the dairy industry. This cross-sectional study aimed to determine farmers’ knowledge, attitude, and practices with respect to lactational intramammary antimicrobial use (AMU) and antimicrobial resistance (AMR) in Swiss dairy herds. Based on their approach towards subclinical mastitis (SCM) and non-severe cases of clinical mastitis (CM), subgroups of farmers were identified and compared regarding their knowledge, attitude and practices towards AMU and AMR. After conducting qualitative interviews to develop a questionnaire, an online survey was sent to 1296 randomly selected Swiss dairy farmers. Information was gathered on demographic data and farmers’ knowledge, attitude, and practices towards AMU and AMR. A latent class analysis was performed to identify subgroups of farmers based on management of SCM and non-severe CM cases. Based on the results of 542 completed questionnaires, poor knowledge with respect to AMU and AMR was identified, as well as discrepancies between farmers’ perceptions and their actual practices. Farmers approached cows with SCM and non-severe CM similarly, indicating they perceived both mastitis states as the same disease. Intramammary antimicrobial products containing cefquinome, which is a highest priority critically important antimicrobial, were among the 3 most commonly applied intramammary antimicrobials. Five latent classes of farmers were identified based on their management towards SCM and non-severe CM. One group of farmers (18.5% of respondents) indicated that they did not treat those mastitis cases, one group only treated SCM cases (13.8% of respondents), one group only treated non-severe CM cases (28.6% of respondents) and the largest group treated both mastitis states (39.1% of respondents). The latter group was subdivided into a latent class of farmers following guidelines for AMU/AMR (25.5% of respondents) and a group of farmers that were not strictly following these guidelines (13.7% of respondents). Regional differences between farmers, according to altitude and language region, explained some of the variation in latent class membership. Latent class membership was associated with farmers’ attitude to use antimicrobials as little as possible and with using antimicrobials only after performing bacteriological and susceptibility testing. This study gave detailed insight into Swiss farmers’ knowledge, attitude, and practices regarding AMU and AMR and provides opportunities to improve antimicrobial stewardship in Swiss dairy herds. The identified groups of farmers, based on their management practices regarding SCM and non-severe CM, may help to design tailored intervention strategies for improving prudent AMU in the heterogeneous population of dairy farmers in Switzerland.</p

Trends in somatic cell count deteriorations in Dutch dairy herds transitioning to an automatic milking system

Udder health is at risk when herds transition from a conventional milking system (CMS) to an automatic milking system (AMS). Somatic cell counts (SCC) are generally elevated for several months following a transition. However, such observations were made in studies conducted in the early 2000s. Technical improvements to AMS have likely been made since then, and farm management may have improved, learning from past experiences. This longitudinal observational study quantified national trends in SCC deteriorations in dairy herds that transitioned from a CMS to an AMS. Census data from the Dutch test day recording was used to determine these trends. It consisted of all cow-level SCC measurements conducted in the Netherlands from January 1, 2007 to December 31, 2019. Three udder health indicators, including the natural logarithm of the yield-corrected bulk-milk SCC, the proportion of cows having a composite SCC ≥200,000 cells/mL, and the proportion of cows having a new elevated SCC, were evaluated using multivariable population-averaged generalized estimation equations. Predicted values resulting from these statistical models were interpreted to determine trends in SCC deteriorations from 12 mo before and 12 mo after the transition to an AMS. Decreasing SCC deteriorations were observed during the study period for all 3 udder health indicators. Udder health deteriorations around the transition to an AMS were still observed, but they decreased in magnitude over the course of the study period. Bulk-milk SCC deteriorations were, for instance, 2.5 times lower in 2019 compared with those observed in 2007. Therefore, the effect of transitioning to an AMS on udder health became less severe in more recent years. However, deteriorations in the proportion of new SCC elevations were still evident toward the end of the study period. Efforts to lower udder health deteriorations in herds that transition to an AMS should therefore be continued and should intensify on factors lowering the proportion of cows having a new elevated SCC.</p

Disentangling the relationships between lameness, milking frequency and milk production in Dutch dairy herds using an automatic milking system

Lameness in dairy cattle commonly results in milk production losses. Previous studies have quantified this effect in cows milked with conventional milking systems. The effect of lameness on milk production in herds with automatic milking systems (AMS) might differ because lame cows may visit the AMS less frequently, resulting in an additional milk production loss. This observational study aimed to quantify the direct and indirect effect, through milking frequency, of lameness on milk production in AMS herds by means of a multilevel mediation analysis. Lameness scores, the number of visits to the AMS, and daily milk production records of 1608 dairy cows from 87 Dutch AMS herds were available for analysis. Of those cows, 27 % were mildly lame and 11 % were severely lame. Using a multilevel Poisson regression model, both mildly lame and severely lame cows were identified to visit the AMS less frequently. A separate multilevel linear regression model identified that the direct effect of severe lameness on milk production was 1.4 kg per day. The subsequent multilevel mediation analysis showed that the relationship between severe lameness and milk production was mediated through a reduced milking frequency; 63 % of the total milk production losses (3.9 kg per day) were due to a reduced milking frequency (2.5 kg per day). The mediating effect of a reduced milking frequency was most prominent in cows with parity ≥ 4 and in cows that were ≥ 30 days in lactation. This study suggests that milk production losses due to severe lameness of dairy cows might be higher in AMS herds compared with cows in herds with a conventional milking system, a likely result of a reduced milking frequency of those cows. Prevention of severe lameness may be more cost-effective in AMS herds than in herds with a conventional milking system

Quantifying preferences of farmers and veterinarians for national animal health programs : The example of bovine mastitis and antimicrobial usage in Switzerland

Bovine udder health in Switzerland is of a relatively high level. However, antimicrobial usage (AMU) seems high in comparison to other European countries also. A new udder health and AMU improvement program could improve this situation but it is uncertain whether there is support from the field. This study aimed to quantify preferences of dairy farmers and veterinarians for the start and design characteristics of a new national udder health and AMU improvement program in Switzerland. A total of 478 dairy farmers and 98 veterinarians completed an online questionnaire. Questions on their demographics and their mindset toward AMU were complemented with an adaptive choice-based conjoint interview, a novel conjoint analysis technique to quantify preferences of respondents for characteristics of a product for which multiple trade-off decisions must be made (here a bovine udder health and AMU improvement program). The conjoint analysis was followed by a multivariate multiple regression analysis to identify groups of respondents with different program design preferences. Logistic regression models were used to associate covariates with respondents' preference to start a new udder health and AMU improvement program. Most farmers (55%) and veterinarians (62%) were in favor of starting a new voluntary udder health and AMU improvement program, but the program design preferences agreed moderately between the two stakeholder groups. Farmers preferred an udder health and AMU improvement program that did not contain a penalty system for high AMU, was voluntary for all dairy herds, and aimed to simultaneously improve udder health and reduce AMU. Veterinarians preferred a program that had the veterinary organization and the government taking the lead in program design decision making, did not contain a penalty system for high AMU, and aimed to simultaneously improve udder health and reduce AMU. Differences between groups of farmers and veterinarians concerning their start preference were identified. Also, the magnitude of various program design preferences changed for farmers with different opinions toward AMU. The information obtained from this study may support the decision-making process and the communication to the field afterward, when discussing national strategies to improve udder health and AMU in Switzerland

Hormone use for reproductive diseases and heat induction in relation to herd-level reproductive performance in Dutch dairy farms

This ecological study aimed to associate hormone use for reproductive diseases and heat induction with reproductive performance at herd level. Hormone use, herd characteristics, and test-day recording data were obtained from 754 representative Dutch dairy farms belonging to five large veterinary practices from 2017 to 2019 (1679 observations in total). Hormone use was classified into prostaglandin, gonadotropin-releasing hormone (GnRH), and progesterone, and was expressed at herd level as the annual number of hormone doses per 100 adult dairy cows. Hormone use was categorized into four levels (no usage, low, medium, and high use), following the 33rd and 66th percentiles of herds that applied them. Three herd-level reproductive performance indicators (calving interval, calving-to-1st insemination interval, number of inseminations per cow) were analyzed using multivariable General Estimating Equations models. The median annual total hormone use was 36.1 (mean=43.1; min=0.0; max=248.2) doses per 100 adult dairy cows in all herds while the median was 39.2 (mean=46.8; min=0.4; max=248.2) doses per 100 adult dairy cows among the user-herds. The median annual group-specific hormone use was 21.3 (mean=26.1; min 0.0; max=180.0), 11.0 (mean=15.3; min=0.0; max=127.0) and 0.0 (mean=1.8; min=0.0; max=40.3) doses per 100 adult dairy cows for prostaglandin, GnRH, and progesterone, respectively. The final statistical models identified that herds with a high hormone use had a calving interval and a calving-to-1st insemination interval that was 9.3 ± 2.6 and 16.4 ± 2.1 days shorter than that of non-user herds (424.0 ± 2.7 and 114.0 ± 2.1 days), respectively. Furthermore, high-user herds needed on average 0.3 ± 0.04 inseminations more to get their cows pregnant compared to non-user herds (1.83 ± 0.04 no. of inseminations per cow). Medium-user herds had a 6.5 ± 2.6 days shorter calving interval and a 12.0 ± 2.1 days shorter calving-to-1st insemination interval with 0.2 ± 0.04 additional inseminations per cow compared to non-user herds. Low-user herds had a 6.2 ± 2.7 days shorter calving interval and a 7.9 ± 2.2 days shorter calving-to-1st insemination interval compared to non-user herds. The model produced the same trend for prostaglandin and GnRH use, with the higher use being associated with a shorter calving interval, a shorter calving-to-1st insemination interval, and a higher insemination per cow number. For progesterone use the opposite effect was observed. In conclusion, using a large representative herd-level dataset, hormone use was associated with a better reproductive performance in terms of calving interval and calving-to-1st insemination interval but gave extra average number of inseminations per cow. It should be monitored how reproduction performance changes when striving for a more prudent hormone use

Intramammary antimicrobial treatment of subclinical mastitis and cow performance later in lactation

The aim of this study was to evaluate long-term therapeutic effects of antimicrobial treatment of recently acquired subclinical mastitis (RASCM) during lactation. Quarter-level clinical mastitis (CM) follow-up, composite somatic cell counts (SCC), and cow-level milk yield later in lactation were evaluated using follow-up data from 2 previously published linked randomized field trials. The first trial randomly assigned antimicrobial treatment with any intramammary product or negative control to culture-positive quarters of cows having a first elevated composite SCC after 2 consecutive low composite SCC measurements. Untreated cows that had a second elevated composite SCC at the next measurement and were staphylococci-positive (i.e., Staphylococcus aureus or non-aureus staphylococci) were randomly assigned to treatment or control. Quarter-level CM cases were reported by the participating herd personnel, and milk yield and composite SCC data were obtained from the regular test-day recording. Frailty survival models were used to evaluate the long-term therapeutic effects of antimicrobial treatment of RASCM on quarter-level CM follow-up. Mixed linear regression models were applied to quantify the effect on milk yield and composite SCC. Data of 638 quarters from 486 cows in 38 herds were available for statistical analyses, of which 229 quarters of 175 cows received antimicrobial treatment for RASCM. Antimicrobial treatment culminated in reduced composite SCC levels later in lactation but did not result in different milk yield levels or CM follow-up compared with control cows. Antimicrobial treatment of cows with RASCM should therefore only be considered in exceptional situations given the current focus on antimicrobial usage reduction in animal husbandry

Intramammary antimicrobial treatment of subclinical mastitis and cow performance later in lactation

The aim of this study was to evaluate long-term therapeutic effects of antimicrobial treatment of recently acquired subclinical mastitis (RASCM) during lactation. Quarter-level clinical mastitis (CM) follow-up, composite somatic cell counts (SCC), and cow-level milk yield later in lactation were evaluated using follow-up data from 2 previously published linked randomized field trials. The first trial randomly assigned antimicrobial treatment with any intramammary product or negative control to culture-positive quarters of cows having a first elevated composite SCC after 2 consecutive low composite SCC measurements. Untreated cows that had a second elevated composite SCC at the next measurement and were staphylococci-positive (i.e., Staphylococcus aureus or non-aureus staphylococci) were randomly assigned to treatment or control. Quarter-level CM cases were reported by the participating herd personnel, and milk yield and composite SCC data were obtained from the regular test-day recording. Frailty survival models were used to evaluate the long-term therapeutic effects of antimicrobial treatment of RASCM on quarter-level CM follow-up. Mixed linear regression models were applied to quantify the effect on milk yield and composite SCC. Data of 638 quarters from 486 cows in 38 herds were available for statistical analyses, of which 229 quarters of 175 cows received antimicrobial treatment for RASCM. Antimicrobial treatment culminated in reduced composite SCC levels later in lactation but did not result in different milk yield levels or CM follow-up compared with control cows. Antimicrobial treatment of cows with RASCM should therefore only be considered in exceptional situations given the current focus on antimicrobial usage reduction in animal husbandry

Antibiotic use and potential economic impact of implementing selective dry cow therapy in large US dairies

In this study, our objectives were to evaluate the economic feasibility of implementing selective dry cow therapy (SDCT) in large US herds and to estimate the potential reduction in antibiotic use around the dry period if SDCT management is adopted. Cow-level data were obtained from the Dairy Herd Improvement Association (AgriTech, Visalia, CA) and individual dairy herds in California. Logistic regression models were used to predict the incidence risk of subclinical and clinical mastitis in the subsequent lactation for 96 last test-day somatic cell score categories. Linear programming was used to optimize the costs of dry cow therapy in 3 simulated large US dairy herds with different bulk tank somatic cell counts (BTSCC). The objective function was aimed at minimization of the total cost of mastitis around the dry period (TCMD), under a varying constraint of the maximum percentage of cows dried off with antibiotics. A sensitivity analysis was performed on milk price, dry-off antibiotic price, and risk ratio of mastitis in the subsequent lactation when no antibiotics and only teat sealant was used at dry-off. For all situations, blanket dry cow therapy was more expensive than SDCT. In a herd with medium BTSCC, the TCMD was $54.7 per primiparous dry cow and$58.5 per multiparous dry cow annually. In the optimal economic situation where SDCT was used, only 30% of primiparous cows received antibiotics, leading to a TCMD of $52.4 per primiparous dry cow, whereas 88$58.2 per multiparous dry cow. This corresponded with an overall reduction of 29% in the use of antibiotics around the dry period in a conservative scenario. This study showed that it is economically feasible to reduce antibiotic use associated with dry cow therapy in large US dairy herds. This contributes to the efforts of reducing antibiotic use worldwide.</p

Intramammary antimicrobial treatment of subclinical mastitis and cow performance later in lactation

The aim of this study was to evaluate long-term therapeutic effects of antimicrobial treatment of recently acquired subclinical mastitis (RASCM) during lactation. Quarter-level clinical mastitis (CM) follow-up, composite somatic cell counts (SCC), and cow-level milk yield later in lactation were evaluated using follow-up data from 2 previously published linked randomized field trials. The first trial randomly assigned antimicrobial treatment with any intramammary product or negative control to culture-positive quarters of cows having a first elevated composite SCC after 2 consecutive low composite SCC measurements. Untreated cows that had a second elevated composite SCC at the next measurement and were staphylococci-positive (i.e., Staphylococcus aureus or non-aureus staphylococci) were randomly assigned to treatment or control. Quarter-level CM cases were reported by the participating herd personnel, and milk yield and composite SCC data were obtained from the regular test-day recording. Frailty survival models were used to evaluate the long-term therapeutic effects of antimicrobial treatment of RASCM on quarter-level CM follow-up. Mixed linear regression models were applied to quantify the effect on milk yield and composite SCC. Data of 638 quarters from 486 cows in 38 herds were available for statistical analyses, of which 229 quarters of 175 cows received antimicrobial treatment for RASCM. Antimicrobial treatment culminated in reduced composite SCC levels later in lactation but did not result in different milk yield levels or CM follow-up compared with control cows. Antimicrobial treatment of cows with RASCM should therefore only be considered in exceptional situations given the current focus on antimicrobial usage reduction in animal husbandry.</p